Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea

키워드

참고문헌 (10)

1. 안지영, "Therapeutic New Era for Atopic Dermatitis: Part 1. Biologics", Annals of Dermatology, 33(1), pp.1~10 (2021), 대한피부과학회[DOI]
2. 안지영, "Therapeutic New Era for Atopic Dermatitis: Part 2. Small Molecules", Annals of Dermatology, 33(2), pp.101~107 (2021), 대한피부과학회[DOI]
3. Halling AS, "Real-world evidence of dupilumab efficacy and risk of adverse events : a systematic review and meta-analysis", J Am Acad Dermatol, 84, pp.139~147 (2021)
4. Agache I, "Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis : a systematic review for the EAACI biologicals guidelines", Allergy, 76, pp.45~58 (2021)
5. Alexis AF, "Efficacy of dupilumab in different racial subgroups of adults with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials", J Drugs Dermatol, 18, pp.804~813 (2019)
6. 김정은, "2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity", Annals of Dermatology, 31(6), pp.654~661 (2019), 대한피부과학회[DOI]
7. Jang DH, "Retrospective study of dupilumab treatment for moderate to severe atopic dermatitis in Korea : efficacy and safety of dupilumab in real-world practice", J Clin Med, 9, pp.1982~ (2020)
8. Kato A, "Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis", J Dermatol, 47, pp.1013~1019 (2020)
9. Uchida H, "One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis : a single-center retrospective study", J Am Acad Dermatol, 84, pp.547~550 (2021)
10. Tavecchio S, "Efficacy of dupilumab on different phenotypes of atopic dermatitis : one-year experience of 221 patients", J Clin Med, 9, pp.2684~ (2020)

관련 논문AI추천